Clinical trial · Observational
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection: a Diagnostic Study
NCT05901376CI-TRIAL-00067105unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients. The main question it aims to answer is: \- Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer? Participants will be asked for their consent to obtain 5 cc of blood.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| MicroRNAs | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MicroRNA | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Gastric Cancer
- interventionNames
- Diagnostic Test: MicroRNA
- label
- Control
- interventionNames
- Diagnostic Test: MicroRNA
Primary outcomes (5)
- measure
- The different of MiR-20a level between gastric cancer and control group
- timeFrame
- Day 1
- description
- The different of MiR-20a level between gastric cancer and control group
- measure
- The different of MiR-21 level between gastric cancer and control group
- timeFrame
- Day 1
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria for Gastric Cancer group: * Recently diagnosed gastric cancer * Never received any treatment for gastric cancer Inclusion Criteria for Control group: * Age 50 or above * Underwent elective upper gastrointestinal endoscopy and negative for gastric cancer * No prior history of gastric dysplasia or cancer Exclusion Criteria: * Patients who cannot give informed consent * Pregnancy * Lymphoma
References
Publications (0)
Data not yet available
No reference posted for this study.